中国感染控制杂志2019，Vol.18Issue(2)：120-126,7.DOI:10.12138/j.issn.1671-9638.20193827
中国临床微生物室参与医院感染及抗菌药物使用管理的现状
Current situation of Chinese clinical microbiological laboratories participating in management of healthcare-associated infection and antimicrobial use
摘要
Abstract
Objective To investigate current situation of Chinese clinical microbiological laboratories participating in management of healthcare-associated infection and antimicrobial use.Methods Fourteen provinces (municipalities), autonomous regions and army hospitals in seven regions of China were selected, the participation of clinical microbiological laboratories in the consultation of HAI diseases, specimen quality control, antimicrobial use, and management of multidrug-resistant organisms (MDROs) before 2000 and every five years from 2000 to 2015 were investigated, the surveyed results were analyzed statistically.Results A total of 187 hospitals were investigated, in 2015, 96 and 172 hospitals (51.34％, 91.98％) participated in the consultation of infectious diseases and multi-department collaborative management on MDROs respectively.However, 44 hospitals (23.53％) still manually performed statistical analysis on drug susceptibility, only 26 hospitals (13.90％) had the ability of identifying homology of pathogens.Rate of MDRO surveillance data feedbacked to clinical departments increased from 66.84％ (n=125) in 2010 to 95.72％ (n=179) in 2015, the frequency of feedback was mainly monthly and quarterly;rate of antimicrobial susceptibility results feedbacked to clinic departments increased from 62.03％ (n=116) to 94.12％ (n=176), 82.35％ (n=154) of clinical microbiological laboratories conducted quarterly feedback;the quality control rate of microscopic sputum smear before sputum culture increased from63.10％ (n=118) to 87.17％ (n=163);rate of bilateral double blood culture increased from 35.83％ (n=67) to 72.73％ (n=136);rates of other aseptic body fluid culture (except blood and urine) increased from 4.86％ to 5.74％;differences were all significantly different between 2010 and 2015 (all P＜0.05).Conclusion Clinical microbiological laboratories have played an important role in promoting the development of HAI management in China, especially during the period of 2011-2015.However, the homology analysis on HAI pathogens, informatization of result feedback, and sterile body fluid specimens detection need to be further strengthened.关键词
临床微生物/医院感染/标本质量控制/多重耐药菌/抗菌药物管理Key words
clinical microbiology/healthcare-associated infection/specimen quality control/multidrug-resistant organism/antimicrobial management分类
医药卫生引用本文复制引用
徐艳,杨怀,陈黎媛,张曼,张满,杨廷秀,朱艳秋..中国临床微生物室参与医院感染及抗菌药物使用管理的现状[J].中国感染控制杂志,2019,18(2):120-126,7.基金项目
贵州省科技计划项目黔科合基础[2016]1509号 （）
中国医院协会《中国医院感染管理工作30周年总结》项目(CHA-2016-026-053) （CHA-2016-026-053）
